previou
studi
suggest
pathogen
flavivirus
dengu
viru
activ
complement
lead
consumpt
complement
protein
sever
diseas
confirm
complement
activ
occur
vivo
wnv
infect
compar
level
function
serum
naiv
wnvinfect
mice
use
erythrocyt
hemolysi
assay
fig
day
wnv
infect
time
point
peak
viremia
observ
see
fig
decreas
function
activ
p
measur
signific
decreas
albeit
smaller
also
note
day
infect
p
activ
also
reduc
day
wnv
infect
fig
b
catabol
vivo
gener
fragment
western
blot
analysi
perform
serum
wnvinfect
mice
antibodi
increas
level
fragment
observ
serum
day
wnv
infect
fig
c
ident
fragment
confirm
absenc
serum
congen
mice
collect
experi
suggest
wnv
infect
activ
consum
complement
within
day
infect
assess
mechan
complementmedi
protect
wnv
diseas
function
classic
classic
lectin
altern
pathway
complement
activ
control
wnv
evalu
morbid
mortal
wildtyp
congen
factor
fd
factor
b
fb
mice
mice
group
exhibit
clinic
sign
infect
includ
weight
loss
hunch
fur
ruffl
decreas
activ
howev
mice
defici
individu
complement
activ
pathway
vulner
infect
higher
mortal
rate
compar
wildtyp
mice
fig
wherea
wildtyp
mice
succumb
infect
n
p
n
p
n
p
n
p
mice
die
wnv
infect
fig
complement
defici
associ
enhanc
suscept
infect
mice
defici
receptor
surviv
rate
similar
wildtyp
mice
n
p
although
fb
fd
compon
altern
pathway
defici
fb
caus
greater
mortal
wnv
infect
p
possibl
caus
residu
altern
pathway
activ
mice
overal
mice
suscept
lethal
wnv
infect
either
mice
p
increas
suscept
mice
also
reflect
decreas
mean
time
death
wildtyp
mice
mice
p
statist
signific
decreas
mean
time
death
observ
mice
thu
defici
complement
activ
pathway
result
increas
mortal
wnv
infect
sever
phenotyp
observ
mice
combin
defici
classic
lectin
pathway
complet
defici
altern
pathway
throughout
time
cours
infect
viremia
limit
detect
direct
plaqu
assay
sampl
unpublish
data
howev
viral
rna
measur
quantit
rtpcr
assay
addit
inform
obtain
wildtyp
mice
viremia
peak
day
infect
decreas
next
sever
day
signific
differ
viremia
observ
time
point
infect
mice
fig
p
variat
among
complementdefici
mice
occur
mice
slightli
higher
wnv
rna
level
wildtyp
mice
n
p
day
infect
previou
experi
shown
defici
result
delay
clearanc
wnv
spleen
assess
complement
pathway
contribut
viral
clearanc
spleen
evalu
wnv
burden
mice
fig
b
compar
wildtyp
mice
observ
slight
delay
clearanc
wnv
spleen
subset
mice
day
infect
mice
respect
detect
infecti
wnv
spleen
wherea
wildtyp
mice
infecti
viru
time
point
day
infect
mice
still
measur
infecti
viru
spleen
wherea
longer
detect
wildtyp
mice
surprisingli
infecti
viru
never
recov
spleen
mice
point
time
cours
n
time
point
consist
peak
viral
replic
spleen
lower
level
wnv
rna
detect
quantit
rtpcr
spleen
mice
compar
wildtyp
mice
fig
c
p
peak
viral
burden
number
posit
sampl
spleen
also
significantli
lower
absenc
p
wherea
wildtyp
spleen
sampl
posit
infecti
viru
day
infect
mice
infecti
viru
moreov
day
infect
lower
level
wnv
rna
detect
spleen
mice
p
thu
spleen
classic
pathway
activ
appear
necessari
product
infect
wherea
altern
pathway
contribut
part
rapid
clearanc
wnv
decreas
wnv
burden
spleen
mice
predict
previou
studi
mice
indic
macrophag
b
cell
princip
cellular
target
wnv
infect
spleen
infect
mice
result
normal
viremia
hypothes
viru
must
replic
anoth
peripher
tissu
studi
group
other
indic
drain
lymph
node
earli
site
wnv
replic
determin
one
possibl
sourc
viremia
anim
viral
burden
inguin
lymph
node
measur
quantit
rtpcr
fig
equival
level
wnv
rna
detect
first
second
day
infect
wildtyp
mice
p
howev
infect
fourfold
less
wnv
rna
found
drain
inguin
lymph
node
p
mice
p
compar
wildtyp
mice
distinct
pattern
wnv
invas
accumul
spinal
cord
observ
mice
fig
agreement
publish
studi
wnv
detect
spinal
cord
sampl
wildtyp
mice
day
infect
similarli
infecti
viru
recov
spinal
cord
mice
day
infect
absenc
either
fb
howev
wnv
detect
subset
spinal
cord
sampl
earlier
day
mice
measur
infecti
wnv
spinal
cord
p
overal
complementdefici
mice
significantli
higher
peak
spinal
cord
viral
burden
day
infect
compar
wildtyp
mice
p
addit
wherea
complementdefici
mice
exhibit
wnv
invas
spinal
cord
day
infect
wildtyp
mice
infecti
wnv
spinal
cord
time
point
result
suggest
differ
complement
activ
pathway
modul
entri
accumul
wnv
spinal
cord
slightli
differ
pattern
infect
observ
brain
earlier
viral
invas
observ
complementdefici
mice
fig
c
infecti
viru
recov
brain
wildtyp
adult
mice
day
result
agre
previou
studi
contrast
infecti
viru
detect
day
brain
mice
averag
mice
higher
level
wnv
brain
mice
day
infect
p
viral
burden
brain
peak
wildtyp
mice
day
infect
contrast
level
infecti
wnv
continu
rise
mice
higher
level
observ
day
infect
p
analysi
viral
burden
cn
suggest
defici
primarili
altern
pathway
result
earlier
wnv
entri
accumul
wherea
defici
complement
pathway
result
increas
viral
load
evalu
enhanc
cn
wnv
infect
result
chang
viral
tropism
examin
brain
spinal
cord
section
wnv
antigen
fig
unpublish
data
wnv
antigen
local
cell
stain
posit
neuron
antigen
unpublish
data
throughout
brain
spinal
cord
agreement
previou
studi
intens
antigen
stain
complementdefici
mice
observ
neuron
cerebellum
brain
stem
brain
base
cortex
less
intens
antigen
stain
cn
tissu
note
wildtyp
mice
sporad
infect
similar
neuron
popul
thu
neuron
throughout
brain
spinal
cord
infect
higher
level
absenc
complement
activ
compar
wildtyp
anim
product
antiwnv
antibodi
depress
mice
assess
kinet
specif
antivir
igm
igg
product
mice
consist
previou
studi
wildtyp
mice
wnvspecif
igm
detect
day
infect
fig
wnvspecif
igg
detect
day
infect
fig
b
near
normal
develop
antiwnv
igg
igm
observ
absenc
altern
pathway
activ
mice
p
addit
mice
observ
signific
differ
isotyp
specif
fig
c
neutral
activ
wnv
antibodi
respons
fig
contrast
develop
wnvspecif
igg
delay
mice
three
fourfold
reduc
titer
day
infect
respect
p
howev
deficit
disappear
day
normal
level
antiwnv
igg
subsequ
observ
p
throughout
time
cours
antiwnv
igm
respons
reduc
absenc
p
collect
serolog
data
establish
igm
respons
wnv
depend
yet
fd
fb
independ
suggest
possibl
role
lectin
pathway
consist
mice
normal
antiwnv
igm
igg
respons
day
infect
unpublish
data
p
cell
requir
clearanc
wnv
cn
studi
influenza
lymphocyt
choriomeningit
viru
lcmv
found
virusspecif
cell
prime
inhibit
absenc
enhanc
wnv
accumul
cn
observ
complementdefici
mice
examin
individu
complement
pathway
defici
affect
respons
cell
wnv
infect
fig
evalu
intracellular
express
splenocyt
mock
wnvinfect
mice
day
infect
increas
total
number
splenic
cell
express
wildtyp
p
mice
p
increas
express
observ
splenocyt
wnvinfect
mice
thu
data
suggest
altern
pathway
complement
activ
requir
full
cell
respons
wnv
infect
traffick
effector
cell
wnvinfect
cn
tissu
requir
cellular
activ
upregul
select
chemokin
receptor
independ
measur
cell
activ
test
pathway
complement
activ
requir
cell
migrat
cn
wnvinfect
anim
isol
braininfiltr
leukocyt
day
infect
wildtyp
mice
quantifi
cell
flow
cytometri
fig
c
isol
averag
cell
cell
brain
n
wildtyp
mice
consist
express
data
number
infiltr
cell
reduc
significantli
absenc
either
fb
n
p
differ
cn
cell
migrat
observ
absenc
either
compart
n
p
collect
data
suggest
lectin
altern
pathway
complement
activ
requir
normal
cell
respons
cn
traffick
wnv
infect
although
clinic
studi
suggest
increas
complement
activ
may
associ
sever
form
infect
two
relat
virus
flavivirida
famili
dengu
viru
hepat
c
viru
essenti
control
wnv
infect
although
studi
mice
consist
model
complementdepend
control
viral
infect
includ
hsv
influenza
lcmv
investig
systemat
address
differ
activ
pathway
coordin
protect
experi
demonstr
complement
activ
pathway
requir
control
sever
wnv
diseas
virolog
experi
suggest
complement
limit
viral
spread
facilit
clearanc
wnv
within
cn
mani
complement
protein
constitut
express
within
cn
upregul
infect
neurotrop
virus
complement
activ
cn
could
critic
destruct
viral
particl
virusinfect
neuron
cell
altern
defect
observ
prime
adapt
immun
respons
wnv
complementdefici
mice
see
may
result
earlier
spread
andor
decreas
clearanc
complementdefici
mice
near
wildtyp
level
viral
rna
serum
throughout
time
cours
suggest
domin
antivir
role
complement
activ
may
direct
virolysi
igm
fix
complement
classic
pathway
wnv
particl
neutral
effici
vitro
exogen
rabbit
complement
anticip
increas
viremia
mice
howev
observ
transient
increas
viremia
mice
may
secondari
depress
level
antivir
igm
mice
viral
clearanc
serum
known
correl
induct
wnvspecif
igm
day
infect
rel
low
viral
neutral
activ
serum
complement
mice
may
caus
reduc
function
mous
classic
pathway
convertas
prior
vivo
experi
support
antibodymedi
protect
wnv
diseas
significantli
attenu
mice
although
magnitud
kinet
viremia
roughli
equival
earlier
cn
viral
invas
observ
complementdefici
mice
earli
cn
seed
consist
observ
mice
lack
fb
fd
although
mechan
remain
unclear
altern
pathway
activ
initi
phase
infect
could
induc
inflammatori
mediat
facilit
viral
bloodbrain
barrier
cross
gener
peripher
lymphoid
tissu
suggest
modul
bloodbrain
barrier
permeabl
wnv
neuroinvas
notabl
genet
disrupt
antibodi
blockad
altern
pathway
activ
function
significantli
inhibit
secret
human
murin
leukocyt
exposur
group
b
streptococcu
experi
examin
relationship
cn
viral
entri
cytokin
profil
wnv
infect
complementsuffici
defici
mice
may
elucid
molecular
basi
stage
pathogenesi
surpris
result
requir
normal
level
wnv
infect
spleen
drain
lymph
node
absenc
infecti
viru
detect
spleen
less
wnv
rna
measur
day
infect
addit
wnv
infect
drain
inguin
lymph
node
reduc
absenc
begin
day
infect
absenc
fewer
spleen
sampl
contain
less
infecti
viru
wildtyp
anim
less
wnv
rna
detect
spleen
drain
inguin
lymph
node
first
glanc
observ
appear
consist
earlier
vitro
studi
show
complement
antivir
igm
enhanc
wnv
infect
macrophag
although
studi
suggest
igmdepend
fixat
split
product
eg
wnv
enhanc
infect
prior
studi
secret
mice
show
normal
wnv
splenic
infect
base
specul
directli
indirectli
interact
wnv
facilit
splenic
infect
direct
interact
viral
glycoprotein
observ
human
cell
lymphotrop
moloney
murin
leukemia
viru
enhanc
infect
demonstr
vitro
ebola
virus
data
clearli
establish
wnv
infect
spleen
significantli
contribut
viremia
cn
seed
somewhat
paradox
decreas
product
splenic
infect
dramat
alter
induct
primari
antivir
b
cell
immun
respons
wnv
appar
contrast
studi
show
follicular
local
spleen
complement
depend
requir
develop
antibodi
respons
solubl
antigen
vesicular
stomat
viru
wnv
hypothes
b
cell
prime
may
occur
secondari
lymphoid
tissu
altern
despit
absenc
product
viral
infect
spleen
suffici
complementdepend
antigen
trap
occur
antigen
present
prime
antivir
adapt
immun
respons
combin
previou
work
current
experi
indic
develop
protect
antiwnv
antibodi
respons
part
requir
near
normal
antiwnv
antibodi
respons
observ
mice
activ
altern
pathway
requir
prime
antibodi
respons
wnv
result
consist
studi
demonstr
mice
exhibit
normal
b
cell
prime
antigen
observ
transient
delay
develop
antivir
igg
igm
absenc
consist
previou
report
defect
primari
igg
igm
respons
mice
data
suggest
contribut
classic
pathway
antiwnv
antibodi
prime
rel
minor
could
secondari
defect
observ
splenic
infect
sever
defect
antiwnv
antibodi
develop
observ
absenc
igm
respons
blunt
igg
respons
delay
sinc
mice
exhibit
normal
igm
respons
lectin
pathway
could
play
import
role
prime
antivir
igm
wnv
although
studi
directli
evalu
contribut
lectin
pathway
antivir
antibodi
respons
idea
consist
work
hsv
primari
memori
antivir
humor
respons
blunt
mice
defect
mbl
function
lectin
pathway
activ
suggest
predispos
individu
sever
acut
respiratori
syndrom
chronic
hepat
b
infect
specul
lectin
pathway
may
essenti
role
prime
humor
respons
pathogen
emerg
literatur
suggest
essenti
role
complement
prime
antivir
cell
immun
cell
respons
influenza
lcmv
requir
activ
possibl
enhanc
antigen
uptak
present
cell
traffick
infect
organ
effici
ctl
respons
critic
develop
wnv
immun
complementdefici
mice
greatest
mortal
ie
associ
cell
activ
traffick
deficit
previou
studi
solubl
antigen
suggest
immun
complex
trap
contribut
cell
prime
expect
mice
cell
deficit
howev
observ
specul
wnv
antigen
uptak
present
may
reduc
absenc
lectin
pathway
activ
andor
deposit
lectin
pathway
recognit
induc
opson
influenza
viru
deposit
bind
activ
enhanc
antigen
present
human
cell
nonetheless
defect
antivir
cell
respons
mice
could
indirect
attribut
depress
antiwnv
igm
respons
decreas
immun
complex
clearanc
although
experi
necessari
identifi
exact
mechan
studi
novel
describ
role
cell
function
viral
infect
also
observ
requir
altern
pathway
develop
cell
respons
wnv
infect
other
demonstr
reduct
classic
pathwaydepend
membran
attack
complex
format
absenc
altern
pathway
activ
wnv
antigen
present
may
reduc
absenc
fb
failur
amplifi
classic
andor
lectin
pathwayiniti
respons
may
attenu
target
uptak
present
wnv
lymphoid
tissu
altern
engag
may
promot
appropri
cytokin
environ
antivir
cell
prime
product
reduc
treatment
human
monocyt
block
antibodi
natur
ligand
complement
activ
play
critic
role
innat
recognit
neutral
pathogen
vivo
studi
expand
current
knowledg
vivo
mechan
complementmedi
antivir
immun
particular
suggest
activ
complement
distinct
pathway
may
control
pathogen
trigger
differ
effector
arm
antivir
immun
limit
studi
address
precis
mechan
three
complement
activ
pathway
stimul
differ
adapt
immun
respons
differ
could
quantit
qualit
variat
gener
activ
fragment
regardless
fulli
function
complement
cascad
clearli
import
control
clear
wnv
given
antibodi
cell
essenti
protect
intrigu
consid
sever
wnv
infect
human
occur
infrequ
could
common
patient
dysfunct
complement
respons
although
complet
defici
complement
protein
rare
heterozyg
defici
mbl
common
associ
increas
risk
viral
diseas
therapi
wnv
becom
avail
import
target
highrisk
popul
depress
level
complement
protein
reduc
complement
activ
could
explain
seemingli
healthi
patient
develop
sever
diseas
wnv
infect
genet
studi
evalu
risk
factor
neuroinvas
wnv
infect
human
includ
analysi
common
complement
gene
allel
polymorph
wnv
strain
isol
new
york
use
studi
mous
experi
use
low
passag
stock
p
propag
aed
albopictu
cell
mice
pure
background
obtain
colleagu
c
gerard
harvard
medic
school
boston
botto
imperi
colleg
london
uk
carrol
harvard
medic
school
boston
g
stahl
harvard
medic
school
boston
h
molina
washington
univers
school
medicin
congen
wildtyp
control
mice
purchas
commerci
jackson
laboratori
mice
hous
pathogenfre
mous
facil
washington
univers
school
medicin
studi
perform
complianc
guidelin
washington
univers
school
medicin
anim
safeti
committe
mice
inocul
subcutan
via
footpad
inject
pfu
dilut
hank
balanc
salt
solut
heat
inactiv
fb
level
function
mous
determin
erythrocyt
hemolysi
assay
previous
describ
brief
sheep
erythrocyt
colorado
serum
co
coat
rabbit
erythrocyt
igg
rockland
immunochem
min
extens
wash
antibodyco
sheep
erythrocyt
mix
guinea
pig
serum
complement
technolog
inc
serial
dilut
mous
serum
naiv
wnvinfect
mice
reaction
incub
h
stop
addit
vol
pb
erythrocyt
pellet
supernat
remov
lysi
measur
use
plate
reader
level
determin
use
normal
human
serum
complement
technolog
valu
hemolyt
complement
activ
determin
describ
previous
complement
activ
assess
western
blot
previous
describ
serum
sampl
collect
naiv
wnvinfect
mice
day
infect
dilut
pb
boil
sd
reduc
sampl
buffer
subject
sd
page
use
gradient
gel
transfer
pvdf
membran
cleavag
product
detect
goat
igg
mp
biomed
follow
horseradish
donkey
igg
f
ab
jackson
immunoresearch
band
visual
use
ecl
plu
chemiluminesc
substrat
system
bd
bioscienc
analysi
viral
burden
organ
recov
day
postinfect
cardiac
perfus
ml
pb
tissu
weigh
homogen
use
beadbeat
apparatu
titrat
wnv
plaqu
assay
cell
describ
previous
serum
obtain
whole
blood
phlebotomi
axillari
vein
immedi
sacrific
viral
rna
prepar
serum
use
qiaamp
viral
rna
recoveri
kit
qiagen
quantifi
realtim
fluorogen
rtpcr
abi
sequenc
detect
system
appli
biosystem
use
primer
probe
correspond
segment
e
gene
describ
previous
viral
rna
extract
lymph
node
spleen
tissu
homogen
use
rneasi
isol
kit
qiagen
quantifi
fluorogen
rtpcr
describ
valu
normal
level
rna
determin
fluorogen
rtpcr
commerci
avail
kit
appli
biosystem
wnvspecif
igm
igg
level
determin
envelop
e
elisa
describ
previous
brief
solubl
wnv
eprotein
coohtermin
hexahistidin
tag
purifi
baculovirusinfect
insect
cell
nickelaffin
chromatographi
use
coat
maxisorp
microtit
plate
nalgen
nunc
overnight
block
pb
bsa
hors
serum
plate
incub
fourfold
serial
dilut
heatinactiv
serum
sampl
overnight
plate
wash
incub
biotinconjug
goat
igm
igg
southern
biotech
follow
strepatavidinhrp
invitrogen
develop
tetramethylbenzidin
substrat
dako
determin
adjust
od
determin
subtract
valu
sampl
block
control
well
titer
repres
serum
dilut
yield
adjust
valu
equival
three
standard
deviat
background
assay
neutral
activ
wnvspecif
antibodi
respons
determin
use
previous
describ
highthroughput
flow
neutral
assay
wnv
viruslik
particl
express
report
gene
green
fluoresc
protein
gfp
wnv
viruslik
particl
incub
serial
dilut
heatinactiv
serum
sampl
incub
permiss
raji
cell
express
dcsignr
later
cell
fix
paraformaldehyd
analyz
flow
cytometri
gfp
express
titer
inhibit
determin
use
graphpad
prism
softwar
brain
spinal
cord
harvest
infect
mice
day
postinfect
perfus
ml
pb
tissu
fix
paraformaldehyd
pb
h
embed
paraffin
section
stain
wnv
infect
use
mab
wnv
e
protein
antigen
retriev
step
dako
cytom
stain
detect
incub
streptavidinconjug
horseradish
peroxidas
develop
diaminobenzidin
slide
counterstain
hematoxylin
facilit
visual
tissu
histolog
intracellular
stain
wildtyp
complementdefici
splenocyt
perform
describ
previous
brief
day
infect
splenocyt
harvest
wildtyp
mice
erythrocyt
lyse
ack
lysi
buffer
mm
mm
splenocyt
count
plate
splenocyt
stimul
ngml
pma
sigmaaldrich
ionomycin
sigmaaldrich
presenc
golgi
plug
bd
pharmingen
h
cell
harvest
stain
either
fitcconjug
antibodi
bd
pharmingen
cell
wash
fix
paraformaldehyd
permeabil
saponin
stain
alexafluor
rat
antibodi
rat
isotyp
control
bd
pharmingen
analyz
flow
cytometri
total
number
cell
determin
multipli
percentag
cell
total
number
splenocyt
harvest
brain
infiltr
cell
isol
quantifi
previous
describ
complementdefici
wildtyp
mice
anaesthet
perfus
ml
pb
day
infect
pfu
wnv
individu
brain
harvest
rpmi
supplement
fb
homogen
press
mesh
tissu
strainer
bd
bioscienc
cell
homogen
centrifug
cell
pellet
resuspend
rpmi
fb
overlaid
isoton
percol
pharmacia
step
gradient
gradient
centrifug
g
min
leukocyt
collect
interfac
leukocyt
three
brain
pool
wash
twice
stain
cell
antibodi
bd
pharmingen
presenc
goat
serum
fc
block
bd
pharmingen
wash
cell
fix
paraformaldehyd
pb
analyz
facscan
becton
dickinson
cellquest
softwar
total
number
cell
brain
determin
multipli
percentag
cell
total
number
leukocyt
harvest
surviv
analysi
kaplanmei
surviv
curv
plot
use
prism
softwar
graphpad
analyz
log
rank
test
statist
signific
complement
level
surviv
time
viral
burden
antivir
antibodi
titer
total
number
activ
cell
analyz
unpair
test
mannwhitney
test
